Information Sharing

Access to the current activities is restricted to CATAG members and can only be accessed by way of Member Login.

In the future, the outcomes of CATAG activities will be collated and made available to members via Member Login. The outcomes of earlier discussions are not available.

Current questions and discussion topics can be accessed via Member Login.

Information sharing and discussion

Between 2005 and 2013, the following topics were considered by CATAG members:

  • Antibiotic surveillance
  • Artesunate
  • Botulinum toxin A: access for non-PBS indications
  • Complementary medicines
  • Conflict of interest documents
  • Current key performance indicator data
  • Drotrecogin (Xigris) guidelines and aggregated audit results
  • e-prescribing
  • Formulary processes
  • Generic medicines: reports of issues
  • Heparins in VTE prophylaxis
  • High cost drug submission documents
  • High risk medicines: Sharing incident data
  • Hydroxycobalamin
  • Individual patient use/individual patient approval forms
  • Key performance indicators
  • Medication Safety Self Assessment/QUM indicators
  • Monoclonal antibodies
  • Naltrexone in Multiple Sclerosis
  • Nifedipine
  • Nitric oxide
  • Nurse Practitioners
  • Off-label use of drugs: list medicines and indications for which off-label use is considered standard practice
  • Oral anticoagulants
  • Paracetamol
  • Pharmaceutical company liaison
  • Product familiarisation programs
  • Self-funding high-cost drugs
  • Using patients own drugs
  • Data Collection

    Off-label use of rituximab: A prospective online survey tool collected data for a six month period April 2012 to October 2012 from Australian public hospitals.
    Publication: O’Connor, K. and Liddle, C.(2013) Prospective data collection of off-label use of rituximab in Australian public hospitals.
    Internal Medicine Journal, 43: 863–870. doi: 10.1111/imj.12206


  • Development of Guiding Principles for the roles and responsibilities of Drug and Therapeutics Committees in Australian public hospitals, 2013
  • Development of Guiding Principles for the quality use of off-label medicines, 2013
  • Leave a Reply